Author details

Full Name

Marcin Kwissa

Affiliation

ORCID

Career Start Year

2000

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36964784	BacSp222 bacteriocin as a novel ligand for TLR2/TLR6 heterodimer.		2023
34466656	Polymersomes Decorated with the SARS-CoV-2 Spike Protein Receptor-Binding Domain Elicit Robust Humoral and Cellular Immunity.	ACS Cent Sci	2021
33851166	Polymersomes decorated with SARS-CoV-2 spike protein receptor binding domain elicit robust humoral and cellular immunity.	bioRxiv	2021
34634664	Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant.	Biomaterials	2021
30643235	Antigens reversibly conjugated to a polymeric glyco-adjuvant induce protective humoral and cellular immunity.	Nature Materials	2019
26682988	Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures.	Immunity	2015
24981333	Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation.	Cell Host Microbe	2014
22238318	Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans.	J Virol	2012
22246032	Distinct TLR adjuvants differentially stimulate systemic and local innate immune responses in nonhuman primates.	Blood	2012
21350488	Programming the magnitude and persistence of antibody responses with innate immunity.	Nature	2011
17931149	The science of adjuvants.	Expert Rev Vaccines	2007
17954572	Adjuvanting a DNA vaccine with a TLR9 ligand plus Flt3 ligand results in enhanced cellular immunity against the simian immunodeficiency virus.	J Exp Med	2007
17722267	Peptide crosslinked micelles: a new strategy for the design and synthesis of peptide vaccines.	Int J Nanomedicine	2006
12879151	Codelivery of a DNA vaccine and a protein vaccine with aluminum phosphate stimulates a potent and multivalent immune response.	Journal of Molecular Medicine	2003
14635042	Breaking tolerance in hepatitis B surface antigen (HBsAg) transgenic mice by vaccination with cross-reactive, natural HBsAg variants.	Eur J Immunol	2003
12601525	Cytokine-facilitated priming of CD8+ T cell responses by DNA vaccination.	Journal of Molecular Medicine	2003
12566707	Selective expression of immunogenic, virus-like particle-derived antibody-binding epitopes.	Intervirology	2002
12039856	Priming polyvalent immunity by DNA vaccines expressing chimeric antigens with a stress protein-capturing, viral J-domain.	FASEB Journal	2002
11485031	Priming of immune responses to hepatitis B surface antigen with minimal DNA expression constructs modified with a nuclear localization signal peptide.	Journal of Molecular Medicine	2001
11504870	Composition and arrangement of genes define the strength of IRES-driven translation in bicistronic mRNAs.	Nucleic Acids Research	2001
10738089	Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control.	Vaccine	2000
10813540	Molecular assessment of post-BMT chimerism using various biologic specimens and automated DNA sizing technology.		2000
11140375	Polyvalent DNA vaccines with bidirectional promoters.	Journal of Molecular Medicine	2000